Hypomethylation may drive CLPB overexpression which predicts poor survival outcomes in breast cancer
Sena Sonmez, Senem Noyan, Tolga Acun
The paper investigates CLPB overexpression in breast cancer, finding hypomethylation of its promoter correlates with poor survival and suggests it as a potential therapeutic target.
bioRxiv · Oct 12, 2025 · PreprintCancer Biology